MUC-1 recognition-based activated drug nanoplatform improves doxorubicin chemotherapy in breast cancer
Si, Pilei, Shi, Jinjin, Zhang, Pei, Wang, Cao, Chen, Haijun, Mi, Xuefang, Chu, Wenling, Zhai, Baoping, Li, WentaoЖурнал:
Cancer Letters
DOI:
10.1016/j.canlet.2019.12.019
Date:
December, 2019
Файл:
PDF, 2.14 MB
2019